The 7th Antibody Industrial Symposium 2019 (AIS2019) congress, organized by the LabEx MAbImprove and MabDesign, offers an ideal conference for researchers, industrials, and clinicians to exchange about therapeutic antibodies.
This year edition will focus on Harnessing the Immune System with mAbs, a major topic chosen by the AIS Scientific Advisory Board constituted by Pierre Fabre, Servier, IRCM, MabDesign, Sanofi, OSE Immunotherapeutics, LFB, CEPR, IGMM, LabEx MabImprove, and Tours University.
Indeed, immune responses can be modulated with therapeutic antibodies and may be harnessed to enhance antibody functions. The AIS2019 will cover the multifaceted mechanisms underlying antibody-mediated immune responses.
Since six years, the AIS has allowed to gather more than 1 300+ participants from 11 different countries, 140+ expert Speakers, held 650+ B2B meetings, presented 30 pitchs, 60+ posters and 70 exhibitors/sponsors.
Join more than 300 experts expected for this new edition, working in the field of mAbs and related services and technologies.
Furthermore, there will be several opportunities for networking, companies to showcase their new products and technologies as well as dedicated time for business partnering.
The topics covered during this meeting are:
- Harnessing the Immune system with Immunomodulatory therapeutic Antibodies
- Immunomodulation via cell membrane antigens
- Immunomodulation with therapeutic antibodies – new strategies & technologies
- Immunomodulation via Soluble Antigens
- Immunomodulation FC – FcyR interactions
CALL FOR ABSTRACTS– Deadline until 29th March 2019
Pitch Session “Immunomodulation with therapeutic antibodies – new strategies & technologies” and Poster session
Has your company or your laboratory developed new approaches to identify new strategies of immunomodulation using mAbs?
Has your company or your laboratory developed an innovative therapeutic antibody and/or an innovative technology to module the immune response?
Do you have a revolutionary method to screen, analyze, validate new mAbs?
You have a research project that may interest the industrial sector working in immunotherapy?
Share your innovative products, new technologies and research projects at the Pitch Session “Immunomodulation with therapeutic antibodies – new strategies & technologies”!
Check the guidelines to submit your abstract:
Deadline until 29th March 2019.
Early Bird Registration until Friday, 29th March 2019 – register early to secure the best rates!
MabDesign members have 20% discount on the registration fee.
For more details on the program, please visit the website at: